Jpmorgan Chase & Co - Sep 30, 2025 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value
Symbol: KPTI
Shares outstanding: 8.73M shares
Disclosed Ownership: 428K shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Date filed: 10/17/2025, 01:55 PM
Date of event: Sep 30, 2025
Previous filing: Jul 16, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	4.9%	428K	428K	0	Rachel Tsvaygoft	Vice President